References
- Pharmaceutical Benefits Advisory Comittee - Recherche Google. [citéd 2021 nov 26]. Avalaible at: https://www.google.com/search?q=Pharmaceutical+Benefits+Advisory+Comittee&rlz=1C1GCEA_enFR901FR901&oq=Pharmaceutical+Benefits+Advisory+Comittee&aqs=chrome.69i57.542j0j3&sourceid=chrome¡UTF-8
- Cleemput I, Neyt M. Belgian guidelines for economic evaluations and budget impact analyses:. second ed. 2012, pp. 84.
- Guidelines for the economic evaluation of health technologies: Canada. CADTH.ca. 2015 [cited 2020 Sept 27]. Available at: https://www.cadth.ca/about-cadth/how-we-do-it/methods-and-guidelines/guidelines-for-the-economic-evaluation-of-health-technologies-canada
- Guide méthodologique: Choix méthodologiques pour l’évaluation économique à la HAS [Internet]. Haute Autorité de Santé. 2020 [cited 2020 Dec 4]. Available at: https://www.has-sante.fr/jcms/r_1499251/fr/choix-methodologiques-pour-l-evaluation-economique-a-la-has
- Institute for quality and efficiency in health care (IQWiG): iQWiG methods resources - general methods version 5.0 of 10 July 2017. [cited 2020 Sept 28]. Available at: https://www.ncbi.nlm.nih.gov/books/NBK332872/?term=iqwig
- Home | HIQA [Internet]. [cited 2021 Nov 26]. Available at: https://www.hiqa.ie/
- Ministerie van Volksgezondheid W en S. Home - national health care institute [Internet]. Ministerie van Volksgezondheid, Welzijn en Sport; 2013 [cited 2021 Nov 26]. Available at: https://english.zorginstituutnederland.nl/
- Home - pharmac | new Zealand Government [Internet]. [cited 2021 Nov 26]. Available at: https://pharmac.govt.nz/
- Dental and pharmaceutical benefits agency (Tandvårds- och läkemedelsförmånsverket, TLV) - government.se [Internet]. [cited 2021c Nov 26]. Available at: https://www.government.se/government-agencies/dental-and-pharmaceutical-benefits-agency-tandvards–och-lakemedelsformansverket-tlv/
- Walter E, Zehetmayr S. [guidelines for health-economic evaluations in Austria]. Wien Med Wochenschr 1946. IPF Institut für Pharmaökonomische Forschung. 2006. dec 156628.
- NICE | the national institute for health and care excellence [Internet]. NICE. NICE; [cited 2021 Nov 26]. Available at: https://www.nice.org.uk/
- About us | institute for clinical & economic review [Internet]. [cited 2021 Nov 26]. Available at: https://icer.org/who-we-are/
- Drummond MF. Methods for the economic evaluation of health care programmes. Fourth ed. New York NY: Oxford, United Kingdom; 2015. p. 464 p.
- Tarride J-E, Blackhouse G, Bischof M, et al. Approaches for economic evaluations of health care technologies. J Am Coll Radiol JACR. mai. 2009;6:307‑16.
- Drummond M, Weatherly H, Ferguson B. Economic evaluation of health interventions. BMJ. 2008 Sep;337(337):a1204.
- Byford S, Raftery J. Economics notes: perspectives in economic evaluation. BMJ. 1998;316(7143):1529‑30.
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg Lond Engl. 2010;8(5):336–41.
- Jaisson-Hot I, Schott A-M, Clippe C, et al. [Methodology of economic assessment: example in oncology]. Bull Cancer (Paris). 2003;90:939‑45.
- Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. Eur J Health Econ HEPAC Health Econ Prev Care. 2009 oct;10:3579.
- Brouwer WBF, van Exel NJA, Baltussen RMPM, et al. A dollar is a dollar is a dollar–or is it? Value Health J Int Soc Pharmacoeconomics Outcomes Res. Oct. 2006;9:341‑7.
- Guerre P, Hayes N, Bertaux A-C. Estimation du coût hospitalier: approches par « micro-costing » et « gross-costing. Rev DÉpidémiologie Santé Publique. 2018;66:S65‑72.